Disclaimers Advertorial Disclosure: This is a paid advertorial
The FDA concluded that the company's manufacturing systems, laboratory controls, and quality oversight failed to comply with Current Good Manufacturing Practice (CGMP) requirements, ultimately classifying products manufactured at the facility as adulterated under the Federal Food, Drug, and Cosmetic Actnot because contamination was confirmed, but because the quality systems could no longer be relied upon
If a reformulated drug demonstrably improves patient outcomes reduced side effects, better adherence, fewer hospitalizations that clinical benefit justifies a price premium even in a Cost Plus environment
This article explains the key differences between CJC-1295 DAC and No DAC, including structure, half-life, signaling pattern, research use, and safety considerations
Saving $200 a month is real money